Annovis Bio Stock Probability of Future Stock Price Finishing Under 6.68
| ANVS Stock | USD 6.71 0.17 2.60% |
Annovis |
Annovis Bio Target Price Odds to finish below 6.68
The tendency of Annovis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 6.68 or more in 90 days |
| 6.71 | 90 days | 6.68 | under 4 |
Based on a normal probability distribution, the odds of Annovis Bio to drop to $ 6.68 or more in 90 days from now is under 4 (This Annovis Bio probability density function shows the probability of Annovis Stock to fall within a particular range of prices over 90 days) . Probability of Annovis Bio price to stay between $ 6.68 and its current price of $6.71 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days Annovis Bio has a beta of 0.76. This suggests as returns on the market go up, Annovis Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Annovis Bio will be expected to be much smaller as well. Additionally Annovis Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Annovis Bio Price Density |
| Price |
Predictive Modules for Annovis Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Annovis Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Annovis Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Annovis Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Annovis Bio is not an exception. The market had few large corrections towards the Annovis Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Annovis Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Annovis Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.43 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 0.86 | |
Ir | Information ratio | -0.11 |
Annovis Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Annovis Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Annovis Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Annovis Bio generated a negative expected return over the last 90 days | |
| Annovis Bio has high historical volatility and very poor performance | |
| Annovis Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (56.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annovis Bio currently holds about 35.97 M in cash with (39.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.41. | |
| Annovis Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20 Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight DelveInsight |
Annovis Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Annovis Stock often depends not only on the future outlook of the current and potential Annovis Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Annovis Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9 M | |
| Cash And Short Term Investments | 5.8 M |
Annovis Bio Technical Analysis
Annovis Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Annovis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Annovis Bio. In general, you should focus on analyzing Annovis Stock price patterns and their correlations with different microeconomic environments and drivers.
Annovis Bio Predictive Forecast Models
Annovis Bio's time-series forecasting models is one of many Annovis Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Annovis Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Annovis Bio
Checking the ongoing alerts about Annovis Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Annovis Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Annovis Bio generated a negative expected return over the last 90 days | |
| Annovis Bio has high historical volatility and very poor performance | |
| Annovis Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (56.2 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Annovis Bio currently holds about 35.97 M in cash with (39.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.41. | |
| Annovis Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20 Key Pharma Companies Actively Working in the Therapeutics Segment DelveInsight DelveInsight |
Additional Tools for Annovis Stock Analysis
When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.